Omalizumab discontinuation in children with severe allergic asthma: An observational real-life study.
Allergy
; 74(5): 999-1003, 2019 05.
Article
in En
| MEDLINE
| ID: mdl-30481388
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Asthma
/
Anti-Asthmatic Agents
/
Omalizumab
Type of study:
Diagnostic_studies
Limits:
Child
/
Humans
Language:
En
Journal:
Allergy
Year:
2019
Document type:
Article
Affiliation country:
Francia
Country of publication:
Dinamarca